Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $474.8700 (-0.2%) ($474.8700 - $474.8700) on Mon. Apr. 12, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.63% (three month average) | RSI | 45 | Latest Price | $474.8700(-0.2%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.4% a day on average for past five trading days. | Weekly Trend | REGN advances 0.7% a week on average for past two weeks. | Market Behavior | Normal for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(51%) XLV(42%) DIA(36%) SPLV(36%) IWD(35%) | Factors Impacting REGN price | REGN will decline at least -0.815% in a week (0% probabilities). VIXM(-20%) TBT(-7%) UUP(-6%) VXX(-5%) IGOV(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.815% (StdDev 1.63%) | Hourly BBV | -0.1 () | Intraday Trend | 0% | | | |
|
Resistance Level | $476.81 | 5 Day Moving Average | $477.42(-0.53%) | 10 Day Moving Average | $477.28(-0.5%) | 20 Day Moving Average | $476.81(-0.41%) | To recent high | -13.5% | To recent low | 6.3% | Market Cap | $50.35b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |